G&A at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s G&A?
- MBX Biosciences, Inc. (MBX) reported G&A of $8.79M in Q1 2026.
- How has MBX Biosciences, Inc.'s G&A changed year-over-year?
- MBX Biosciences, Inc.'s G&A increased by 113.2% year-over-year, from $4.12M to $8.79M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.